New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
08:18 EDTROSGRosetta Genomics provides product pipeline update
Rosetta Genomics announces details regarding the company's plans to advance its proprietary microRNA platform technologies in diagnostics and therapeutics. Kenneth A. Berlin, president and CEO of Rosetta Genomics stated, "Rosetta Genomics continues to set the pace in developing and commercializing microRNA-based technologies. We have the most validated microRNA biomarker platform with approximately 50 peer-reviewed publications relating to our platform and have recently rejuvenated our research and development efforts to leverage this leading and versatile platform. We are moving forward on a variety of important projects to provide clinicians with better tools to improve patients' lives in a number of areas of unmet medical need with an aim to commercialize one new assay per year commencing in 2015. Building upon the company's four current commercial diagnostic assays, Rosetta is advancing several new diagnostic assays starting with our lead assay for the differential diagnosis of thyroid neoplasia. In addition, we are evaluating several assays for other cancers as well as assays for non-invasive diagnosis of chronic kidney rejection; the early diagnosis and risk stratification of heart failure patients; and the early diagnosis and differentiation of Alzheimer's disease."
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
08:31 EDTROSGRosetta Genomics receives U.S. patent allowance for kidney cancer test
Subscribe for More Information
March 25, 2015
08:02 EDTROSGRosetta Genomics to launch Admera's OncoGxOne
Subscribe for More Information
March 17, 2015
08:24 EDTROSGRosetta Genomics to host conference call
Conference call to provide corporate and financial updates will be held on March 17 at 10 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use